IDC Health Insights survey ranks Accenture as top life science IT services vendor

NewsGuard 100/100 Score

Accenture (NYSE: ACN) has been ranked as the number one life science information technology (IT) services vendor in a survey conducted by IDC Health Insights.

“IDC Health Insights' Top 5 Preferred Life Science Technology Vendors for 2011.”

The ranking was contained in a July 2011 report titled, "IDC Health Insights' Top 5 Preferred Life Science Technology Vendors for 2011." The IDC Health Insights survey indicates that respondents expect to contract with Accenture during the next 12 months for IT services. Click here for a link to the report.

"We believe this ranking confirms our strong position in the marketplace, and shows that industry leading life science companies continue to rely on Accenture to provide them with the next generation of IT service solutions that deliver innovation and proven business value," said Mike Rainey, who oversees Accenture's Life Sciences practice. "We are proud to be recognized by IDC Health Insights as the leader in this space."

The IDC Health Insights report is a biannual IT budget-tracking survey of several hundred life science companies. The survey, which polled 135 industry leaders on planned IT budgetary spend, technology priorities and vendor preference, asked participants to identify which vendors servicing the life science market they expect to spend money with on software, hardware, and IT services over the next 12 months.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology